US President Donald Trump on Friday declared that all branded or patented pharmaceutical products imported into the United States will face a 100% tariff starting October 1, 2025, unless their manufacturers are actively building production facilities within the country.

Tariff Rules and Definitions

Trump posted on his social media platform Truth Social, “Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America.”

He clarified that “IS BUILDING” refers to projects that are either ‘breaking ground’ or ‘under construction’. Therefore, no tariff will apply to pharmaceutical products if construction has already started.

Trump has long argued that tariffs encourage companies to invest in domestic factories and reduce reliance on foreign manufacturing.

Impact on Indian Pharma Companies

Experts have raised concerns that the new tariffs could hit Indian pharmaceutical exports hard. A report by SBI Research in August 2025 noted that nearly 40% of India’s pharma exports go to the US. Many large Indian pharma firms earn 40–50% of their revenue from the US market.

The report projected that a 50% tariff on Indian pharma exports could reduce company earnings by 5–10% in FY26. Furthermore, the tariff could make Indian products less competitive in the US market, squeezing profit margins, since companies may not be able to pass the higher costs to consumers. In FY25, India’s share in US pharma imports was 6%.

Tariffs on Other Household Products

Trump had previously announced import taxes on household items:

• 50% on kitchen cabinets and bathroom vanities

• 30% on upholstered furniture

• 25% on heavy trucks

He justified the new tariffs on Truth Social, saying they were necessary for “National Security and other reasons.”

Inflation and Economic Context

Despite imposing new taxes, Trump claims that inflation is no longer a major challenge for the US economy. However, the consumer price index (CPI) rose 2.9% over the past 12 months, up from 2.3% in April when he first introduced sweeping import tariffs.

In 2024, the US imported nearly $233 billion in pharmaceutical and medicinal products, according to the Census Bureau (via Associated Press).

Effect on Housing and Homebuilders

The new tariffs on kitchen cabinets and other household items could raise costs for homebuilders, adding to challenges for buyers already struggling with housing shortages and high mortgage rates.

The National Association of Realtors reported that home sales listings increased 11.7% in August 2025 compared to last year. However, the median price for an existing home remained $422,600, indicating ongoing price pressures in the housing market.

Trump’s new 100% tariff on imported drugs marks a major step in his push for domestic manufacturing. While aimed at reducing foreign dependency, the move could impact global pharmaceutical companies, especially in India, and may also increase costs for American consumers and homebuilders.